August 2010
M T W T F S S
« Jul   Sep »
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Contact us

GVK Power plans to raise US$280mn

GVK Power & Infrastructure is planning to raise US$280 mn (Rs 13bn) from private equity majors 3i Group plc and Actis, according to a report. 3i Group plc and Actis are investing US $140 mn into the company, says reprot. The report stated that company is expanding its power business and has lined up a slew of power projects and the equity would fund this expansion. […]

Kalpathi Investments picks up 45% stake in Primex Healthcare

3i Group plc and Actis are investing US $140 mn into the company GVK Power & Infrastructure is planning to raise US$280 mn (Rs 13bn) from private equity majors 3i Group plc and Actis, according to a report. 3i Group plc and Actis are investing US $140 mn into the company, says reprot. The report stated that company is expanding its power business and has lined up a slew of power projects and the equity would fund this expansion. Rate This Article Average rating : 5.0 Thank you for the rating. You have already rated ! Kalpathi Investments has picked up 45% stake for Rs 5.1 crore in the Chennai-based Primex healthcare, which has plans to set up over 50 premium quality diagnostic facilities at affordable cost across Tamil Nadu over the next 12 months. It will start setting up scans and lab facilities in six locations in Chennai, before expanding into other cities and towns in the State. The Indian diagnostic services industry is projected to grow at a CAGR of over 20% in the next three years. Targeted at all income groups starting from the lower-middle to the upper income group and corporates, Primex plans to offer high-end 1.5T MRI, multi-slice CT, high frequency digital X- ray, 3D ultrasound systems, computerised ECG, treadmill, PFT and EEG. […]

PE funds set to book losses in Gujarat Pipavav Port IPO

This is a story of one port, many funds and negative returns after a decade’s wait—a long-term infrastructure story gone wrong. A private equity (PE) fund managed by AMP Capital Investors of Australia is set to make a substantial loss as it sells a part of its investment in Gujarat Pipavav Port Ltd in the latter’s initial public offering (IPO). It is not alone. There are quite a few other funds that are not happy with their investment in the port operator. In a rare loss-making exit through an IPO in the infrastructure sector, the 11-year-old India Infrastructure Fund Llc will see a 27% erosion in the value of its investment if the issue, which opens on Monday, gets priced at the upper end of the `42-48 price band. At this price, India Infrastructure Fund’s loss will be `18.45-24.45 per share. India Infrastructure Fund was launched in 1999 under a joint management agreement between AMP Capital and the erstwhile Unit Trust of India, or UTI. In 2001, the fund bought 5.9 million shares in Gujarat Pipavav Port for `47 crore at `80 apiece. […]

George Soros buys share of 4 % on the Bombay Stock Exchange

U.S. billionaire investor George Soros has contributed to the Stock Exchange Bombay. Soros Quantum hedge fund had acquired a 4% share of Asia’s oldest exchange, Dubai Financial, said a spokesman for the Bombay Stock Exchange on Friday. For more details, he did not name . One person familiar with the matter that put the investor for the participation of about 380 INR ( the equivalent of $ 8.2 ) per share or a total of about USD 34 million on the table. This is the exchange rate with a total of around 850 million USD. Representatives of Quantum and Dubai Financial were not immediately be reached for comment. At the Bombay Stock Exchange was founded in 1875 more than 4,900 companies are listed . As of 18th June was the public shareholding in the stock market at 56.37 %, the remaining shares were held by exchange members and their associates , as is evident from data on the stock exchange website. […]

Elephant Capital buys stake in ClinTec Intl for Rs 58 cr

Elephant Capital, a private equity firm led by Dabur group promoter Gaurav Baurman, today said it has acquired a minority stake in clinical research firm ClinTec International for 8 million pounds (Rs 58 crore). “Through this investment, Elephant has entered the attractive clinical research base, where ClinTec operates as a global provider of outsourcing solutions addressing the drug development lifecycle,” the company said in a statement. It, however, did not disclose the exact amount of stake picked up by the private equity firm. Burman, who is the Managing Partner of Elephant Capital, and James Hauselein a non-executive director of the firm, have also made personal co-investments of 150,000 pounds (Rs 1.09 crore) and 200,000 pounds (Rs 1.45 crore) respectively in the transaction, it added. […]